Crime News • 2026-08-17 14:35 UTC • By Billy Odell Tucker-Robinson
Nestle shifts strategy on GLP-1 weight-loss drugs, developing protein, collagen and nutrient products to address side effects for users
[▻](https://video.twimg.com/amplify_video/2089357583165296640/vid/avc1/1920x1080/zTHE38tEKreyKONQ.mp4) [↧](https://t.co/C3LfdAUVn5)
📚 More from Billy’s World
Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y •
YouTube: @BankingWithBilly